FDA inspection
Sankyo U.S.A. Development( Div. of Sankyo Pharma, Inc.): FDA inspection ending Mar 30, 2000
FDA inspection 19387 · Official Action Indicated (OAI) · New York, NY
Key facts
| Inspection ID | 19387 |
|---|---|
| Firm | Sankyo U.S.A. Development( Div. of Sankyo Pharma, Inc.) |
| FEI number | 1000521432 |
| Address | 780 3rd Ave Rm 780 |
| City | New York |
| State | NY |
| ZIP | 10017-2024 |
| Fiscal year | 2000 |
| Inspection end date | Mar 30, 2000 |
| Classification | Official Action Indicated (OAI) |
| Project area | Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data